SynthesisFrontiers in psychiatry2025
Implementation of generative AI for the assessment and treatment of autism spectrum disorders: a scoping review.
Synthesis in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence support for diagnosis of neurodevelopmental disorders during childhood: an umbrella review.Frontiers in psychiatry · 2026Pooled it
- Pediatric social robotics in ASD: navigating AI blind-spots toward clinical validation.European journal of pediatrics · 2026Review
- Six artificial intelligence innovation strategies applied to autism spectrum disorder research: A narrative review.Pediatric investigation · 2026Review
- Systematic review and meta analysis of chatbots in the management of depressive and anxiety symptoms.NPJ digital medicine · 2026Article
- Toward FIAPFrontiers in neuroinformatics · 2026Article
- Beyond classification metrics: a psychometric-aware benchmark for data augmentation in imbalanced student mental health surveys.Frontiers in digital health · 2026Article
- AnFrontiers in psychiatry · 2026Article
- Can AI-driven games enhance social skills for autistic children? - A three-level meta-analysis.Frontiers in psychology · 2026Review
- Artificial-intelligence-based developmental screening for pre-school children (ages 3-6): a scoping review of deployed tools, clinical validity, equity, and implementation in guidance-center settings.Frontiers in psychology · 2026Review
- The evolving role of machine learning in autism spectrum disorder: current evidence and future directions.Pediatric research · 2025Review
- Excitatory/Inhibitory balance in autism spectrum disorders: Integrating genetic, neurotransmitter and computational perspectives.AIMS neuroscience · 2025Review
- Speech pattern disorders in verbally fluent individuals with autism spectrum disorder: a machine learning analysis.Frontiers in neuroinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Autism spectrum disorder (ASD) is characterized by persistent deficits in social communication and restrictive, repetitive behaviors. Current diagnostic and intervention pathways rely heavily on clinician expertise, leading to delays and limited scalability. Generative artificial intelligence (GenAI) offers emerging opportunities for automatically assisting and personalizing ASD care, though technical and ethical concerns persist. Methods: We conducted systematic searches in Embase, PsycINFO, PubMed, Scopus, and Web of Science (January 2014 to February 2025). Two reviewers independently screened and extracted eligible studies reporting empirical applications of GenAI in ASD screening, diagnosis, or intervention. Data were charted across GenAI architectures, application domains, evaluation metrics, and validation strategies. Comparative performance against baseline methods was synthesized where available. Results: From 553 records, 10 studies met the inclusion criteria across three domains: (1) screening and diagnosis (e.g., transformer-based classifiers and GAN-based data augmentation), (2) assessment and intervention, (e.g., multimodal emotion recognition and feedback systems), and (3) caregiver education and support (e.g., LLM-based chatbots). While most studies reported potential performance improvements, they also highlighted limitations such as small sample sizes, data biases, limited validation, and model hallucinations. Comparative analyses were sparse and lacked standardized metrics. Discussion: This review (i) maps GenAI applications in ASD care, (ii) compares GenAI and traditional approaches, (iii) highlights methodological and ethical challenges, and (iv) proposes future research directions. Our findings underscore GenAI's emerging potential in autism care and the prerequisites for its ethical, transparent, and clinically validated implementation. Systematic review registration: https://osf.io/4gsyj/, identifier DOI: 10.17605/OSF.IO/4GSYJ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.